Charlotta Otter
- Pharmacology top 0.5%
- Oncology top 10%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 10%
- Genetics
- Co-authors
- Magnus Ingelman‐SundbergTommy B. AnderssonMikael OscarsonBrith LeidvikInger JohanssonCollen MasimirembwaEleni AklilluMats Hidestrand
- Topics
- Pharmacogenetics and Drug Metabolism (12 papers)Drug Transport and Resistance Mechanisms (6 papers)Drug-Induced Hepatotoxicity and Protection (3 papers)
- Cited by
- PharmacologyOncologyTransplantation
- Partner nations
- SwedenUnited KingdomZimbabwe
In The Last Decade
Charlotta Otter
16 papers receiving 866 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 659
- Oncology 391
- Molecular Biology 274
- Pediatrics, Perinatology and Child Health 98
- Genetics 95
Countries citing papers authored by Charlotta Otter
This map shows the geographic impact of Charlotta Otter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Otter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Otter more than expected).
Fields of papers citing papers by Charlotta Otter
This network shows the impact of papers produced by Charlotta Otter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Otter. The network helps show where Charlotta Otter may publish in the future.
Co-authorship network of co-authors of Charlotta Otter
This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Otter. A scholar is included among the top collaborators of Charlotta Otter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Otter. Charlotta Otter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 48 | |
| 3 | 21 | |
| 4 | 201 | |
| 5 | 24 | |
| 6 | 110 | |
| 7 | 6 | |
| 8 | 54 | |
| 9 | 21 | |
| 10 | 146 | |
| 11 | 53 | |
| 12 | 46 | |
| 13 | 92 | |
| 14 | 6 | |
| 15 | 4 | |
| 16 | 7 |
About Charlotta Otter
Charlotta Otter is a scholar working on Pharmacology, Oncology and Endocrinology, having authored 16 papers that have together received 893 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Pharmacology (659 citations), Oncology (391 citations) and Transplantation (23 citations). Charlotta Otter has collaborated with scholars based in Sweden, United Kingdom and Zimbabwe. Frequent co-authors include Magnus Ingelman‐Sundberg, Tommy B. Andersson, Mikael Oscarson, Brith Leidvik, Inger Johansson, Collen Masimirembwa, Eleni Aklillu, Mats Hidestrand, Anna L.V. Johansson and Alan R. Boobis. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.